Lung Cancer
Filters
Lazertinib (Lazcluze) 80mg | Janssen China Originator | GLT
NMPA-approved Lazcluze 利珂 (lazertinib) 80mg x 90 tablets by Xi'an Janssen, third-generation EGFR-TKI originator, China-sourced.
Nivolumab (Opdivo) 40/100/120mg | BMS China Originator | GLT
BMS originator Opdivo (nivolumab) 40mg/4mL, 100mg/10mL & 120mg/12mL vials, China-sourced, PD-1 inhibitor for multiple cancers.
Nivolumab (Nivamo) 40mg/4mL | Ziska Bangladesh Biosimilar | GLT
Nivamo — Ziska Pharmaceuticals nivolumab biosimilar 40mg/4mL vial for PD-1 checkpoint cancer therapy.
Nivolumab (Opdyta) 100mg/10mL | BMS India Originator | GLT
BMS India-market originator Opdyta (nivolumab) 100mg/10mL vial, the same PD-1 inhibitor sold as Opdivo worldwide.
Kadcyla 赫赛莱 Ado-trastuzumab Emtansine (T-DM1) 100/160mg | Roche China Originator | GLT
NMPA-approved Roche Kadcyla 赫赛莱 ado-trastuzumab emtansine (T-DM1) 100mg & 160mg vials, China originator HER2-targeted ADC.
Kadcyla Ado-trastuzumab Emtansine (T-DM1) 100/160mg | Roche EU Originator | GLT
EMA-approved Roche Kadcyla ado-trastuzumab emtansine (T-DM1) 100mg & 160mg vials, EU originator HER2-targeted ADC.
DOVBLERON 达伯乐 (Taletrectinib) 0.2g Capsules | ROS1 Inhibitor | GLT
Innovent-marketed taletrectinib (same molecule as Ibtrozi) for ROS1-positive NSCLC
Pembrolizumab (Keytruda) 100mg/4mL | China-Sourced | GLT
PD-1 inhibitor for multiple cancers — China-sourced, NMPA-approved Keytruda at competitive global pricing
Sort
- Recommended
- Price: Low to High
- Price: High to Low
- Newest
- Best Selling